FDA
label_change
· 2017-03-28
FDA Approved: MOTOFEN — Supplemental Application (Legacy Pharma USA Inc.)
Summary
The FDA approved a supplemental application for MOTOFEN (difenoxin and atropine sulfate) submitted by Legacy Pharma USA Inc., resulting in updated labeling for …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MOTOFEN (DIFENOXIN AND ATROPINE SULFATE)